COLUMBIA, Md., June 7 /PRNewswire-FirstCall/ -- Martek Biosciences
Corporation (Nasdaq: MATK) announced today that it is presenting at the
Fifth Annual Needham & Company, LLC Biotechnology and Medical Technology
Conference in New York. The conference is being held June 14-15, 2006 at
the New York Palace Hotel. Peter L. Buzy, CFO, will be presenting on
Wednesday, June 14, at 1:30 p.m. Eastern Time.
A live audio webcast of Martek's presentation will be available by
accessing the following link:
http://www.wsw.com/webcast/needham15/matk/http://www.wsw.com/webcast/needha
m15
/ctrx/http://www.wsw.com/webcast/needham15/phrm/http://www.wsw.com/webcast/
nee dham15/avgn/
Martek Biosciences Corporation (Nasdaq: MATK) is a leader in the
innovation and development of omega-3 DHA products that promote health and
wellness through every stage of life. The Company produces Martek DHA(TM),
a vegetarian omega-3 fatty acid DHA (docosahexaenoic acid), for use in
foods, infant formula, and supplements, and ARA (arachidonic acid), an
omega-6 fatty acid, for use in infant formula. For more information on
Martek Biosciences, visit http://www.martek.com.
CONTACT: Kyle Stults, Investor Relations of Martek Biosciences
Corporation, +1-410-740-0081.
SOURCE Martek Biosciences Corporation
 back to top
Related links:
http://www.martekbio.com
CONTACT:
Kyle Stults, Investor Relations of Martek
Biosciences Corporation, +1-410-740-0081
|
